Clinical Trial Update: A Study of the Safety, Pharmacokinetics, and Pharmacodynamics of CNTO 3649 in Healthy Adults and Patients With Type 2 Diabetes Mellitus [Phase 1]

View source ↗

Summary

A Phase 1 study assessing the safety, pharmacokinetics, and pharmacodynamics of CNTO 3649 in healthy adults and patients with Type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• CNTO 3649

Snippet

Sponsor: Centocor, Inc. | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED